Brownfield Ag News6h
Lab-grown protein must be labeled in SD
A new law in South Dakota requires lab-grown protein to be labeled. Governor Larry Rhoden has signed House Bill 1022, which ...
Petvivo Signs Exclusive Sales And Marketing Agreement With Vetstem For Preciseprp® Canine And Equine Products
This is a game changer for veterinarians and their ability to treat their patients with PRP”, said Mike Eldred, PetVivo Board Member.“This innovative, and FDA reviewed product, will be a great ...
The overlooked astrocyte: Star-shaped brain cells may form specialized networks for reward learning
Most neuroscience research carried out up to date has primarily focused on neurons, the most renowned type of cell in the ...
The EMBO Journal1d
Portimine A toxin causes skin inflammation through ZAKα-dependent NLRP1 inflammasome activation
In 2020-2021, a mysterious skin disease affected fishermen in Senegal. High levels of Portimine A toxin, produced by the ...
Targeted Oncology2d
Mushtaq Examines Long-Term Toxicities of CAR T-Cell Therapy in Multiple Myeloma
During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...
Innovative target design leads to surprising discovery in laser-plasma acceleration
Scientists have developed a method for generating fast, bright proton beams using a high-repetition-rate laser-plasma ...
Regeneron Pharmaceuticals, Inc.: Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma
Acceptance follows resolution of third-party fill/finish manufacturing issues FDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc.
Linvoseltamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Multiple Myeloma
Acceptance follows resolution of third-party fill/finish manufacturing issues FDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: REGN) today announced ...
Carsgen's First Enrolled Subject In The THANK-U Plustm Platform-Based Allogeneic CAR-T Trial Achieves Scr At Week 4
CARsgen Therapeutics Holdings Limited (Stock Code: 2171), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the first ...
eLife5d
Megakaryocytes assemble a three-dimensional cage of extracellular matrix that controls their maturation and anchoring to the vascular niche
Megakaryocytes form a three-dimensional (3D) cage composed of laminin and collagen IV connected to the basement membrane surrounding them. This microarchitecture stabilizes megakaryocytes within their ...
'Give my son the same support as cancer patients'
The mother of a seven-year-old with a life-threatening blood disorder says despite treatments being the same as cancer, they ...
Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript
Q3 2025 Earnings Conference Call February 6, 2025 8:30 AM ETCompany ParticipantsOlga Guyette - Vice President, ...